Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
Clariane SE is a French company specializing in care services for vulnerable individuals, operating across six European countries: France, Germany, Belgium, Italy, the Netherlands, and Spain. Its core activities are divided into three segments: long-term care, specialty care, and community care. Long-term care includes nursing homes and assisted living facilities; specialty care encompasses post-acute and rehabilitation services, mental health clinics, and home hospitalization; and community care offers shared living solutions and home care services. Founded in 2001 and formerly known as Korian, the company rebranded to Clariane SE in June 2023 and adopted the status of a purpose-driven company, emphasizing its commitment to addressing societal challenges related to aging and vulnerability. Headquartered in Paris, Clariane operates over 1,200 facilities, employing approximately 63,000 staff members. Its strategic positioning focuses on providing personalized care solutions integrated within local communities, leveraging a diversified service portfolio to meet the complex needs of an aging population. (,,)
View stock
VS
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
View stock

Stock highlights

Stock comparison highlights
Stock name
Clariane SEEli Lilly
Last price
€3.19$1,417.54
Currency
EUR
USD
€1.1B$1.3T
95.4146.01
€0.03$30.81
0.820.45
0$6.69
00.49%
Sector
HealthHealth
Employees
70,68550,000
Ticker
€CLARI$LLY
Primary listing
PARNYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in €CLARI or $LLY on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.